CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 538 enrolled
Drug / intervention
Diagnosticother
Likely dose
Not stated in record
Key inclusion· 3
  • ✓Individuals diagnosed with schizophrenia or schizoaffective disorder
  • ✓Parents of individuals with schizophrenia or schizoaffective disorder
  • ✓Matched control group without schizophrenia or schizoaffective disorder
Key exclusion· 4
  • ✕Unable to provide informed consent
  • ✕Psychotic disorder secondary to substance abuse
  • ✕Psychotic disorder secondary to known medical or neurological disorder
  • ✕Severe intellectual disability

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00108303
NCT00108303N/ACompleted
CompareCT.gov

Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes in Individuals Extensively Diagnosed and Genotyped

VA Office of Research and Development·observational·Posted Apr 15, 2005·Updated Jan 7, 2016

In Brief

An observational study evaluating Diagnostic for Schizophrenia. Completed, enrolled 538 participants across 1 site.

Detailed Summary

Schizophrenia has long been known to be an illness with significant evidence for a genetic predisposition. The purpose of this study is to determine the genetic abnormalities that cause childhood and adult onset schizophrenia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 15, 2005
Enrollment StartJan 1, 2004
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 21.2 years ago

Interventions

Diagnosticother

Diagnostic evaluation for schizophrenia. Schizophrenia includes schizophrenia and schizoaffective disorder.